D-8
Today is  2024. 11. 21.

Program
Program at a Glance Scientific Program Invited Speakers

09:00 - 10:40 Symposium 1
2024 Guideline Update for Cardiometabolic Disease
09:00 - 10:40
Symposium 1
2024 Guideline Update for Cardiometabolic Disease

Organizer : Jong-Chan Youn (The Catholic University of Korea, Korea)

  • In this session; we will provide a comprehensive review of the latest guidelines in key areas of cardiometabolic health from the national key opinion leaders.
  • We will start with the current guidelines for hypertension, followed by updates on the management of dyslipidaemia. We will then look at the latest recommendations for the management of diabetes and conclude with the current guidelines for the management of heart failure.

Chairpersons

Sang-Hyun Kim (Seoul National University, Korea)
Kwang Joon Kim (Yonsei University, Korea)

09:00 - 09:20

Current Guidelines for Hypertension

Sungha Park (Yonsei University, Korea)
09:20 - 09:40

Current Guidelines for Dyslipidemia - Overview and Unanswered Questions

Sin Gon Kim (Korea University, Korea)
09:40 - 10:00

Advancing Diabetes Management: Insights from the KDA Clinical Practice Guidelines

Byeong-Wan Lee (Yonsei University, Korea)
10:00 - 10:20

Current Guidelines for Heart Failure

Seong-Mi Park (Korea University, Korea)

10:20 - 10:40

Panel Discussion

Jong-Chan Youn (The Catholic University of Korea, Korea), Minjae Yoon (Seoul National University, Korea)

Jun Hwa Hong (Eulji University, Korea), Suk Chon (Kyung Hee University, Korea)
10:40 - 11:00

Coffee Break
11:00 - 11:10 Opening Address
11:00 - 11:10
Opening Address
11:10 - 11:50 Plenary Lecture 1
11:10 - 11:50
Plenary Lecture 1
  • Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein cholesterol (LDL cholesterol), and most often caused by a defect in 3 different genes (LDL-receptor gene, PCSK 9 gene and Apo B gene). As the FH affects the way the body processes cholesterol, people with FH have a higher risk of heart disease and a greater risk of early heart attack. In this plenary lecture, the world renowned expert in FH research, Professor Brian Tomlinson from Macau University of Science and Technology, Macau, China will provide us with beautiful insights and future perspectives in the field of diagnosis and treatment of FH.

Chairpersons

Won-Young Lee (Sungkyunkwan University, Korea)
11:10 - 11:50

Familial Hypercholesterolaemia, Diagnosis and Management

Brian Tomlinson (Macau University of Science and Technology, Macao SAR)
11:50 - 12:10 Luncheon Symposium 1 [ Daewoong Pharmaceutical ]
11:50 - 12:10
Luncheon Symposium 1 [ Daewoong Pharmaceutical ]

Chairperson

Sang-Hyun Ihm (The Catholic University of Korea, Korea)
11:50 - 12:10

Update on BP Control Strategy in Elderly Patients with Hypertension

Jong-Chan Youn (The Catholic University of Korea, Korea)
12:10 - 13:00

Break
13:00 - 14:40 Symposium 3
Non-Atherosclerotic, Non-Cardioembolic Cerebral Infarction
13:00 - 14:40
Symposium 3
Non-Atherosclerotic, Non-Cardioembolic Cerebral Infarction

Organizer : Sang-Mi Noh (The Catholic University of Korea, Korea)

  • Ischemic stroke is a disease with a variety of etiologies. Most of its cases are due to atherosclerosis which is influenced by traditional vascular risk factors such as diabetes and hypertension or, due to high-risk cardio-embolic sources such as atrial fibrillation.
  • There are well-established guidelines and extensive research concerning the causes and treatment of these types of strokes. In this session, we aim to share the latest research and clinical experiences on non-atherosclerotic, non-cardio-embolic stroke which are rare, yet require different therapeutic approaches.

Chairpersons

Hyung-Min Kwon (Seoul National University, Korea)
Yo Han Jung (Yonsei University, Korea)
13:00 - 13:20

Cervicocephalic Arterial Dissections

Seong-Joon Lee (Ajou University, Korea)
13:20 - 13:40

Antiphospholipid Syndrome and Stroke

Wookjin Yang (Asan Medical Center, Korea)
13:40 - 14:00

Cancer-related Stroke

Joonsang Yoo (Yonsei University, Korea)

14:00 - 14:20

Characteristics of PFO-related Stroke and its Secondary Prevention

Hyung Jun Kim (Sungkyunkwan University, Korea)
14:20 - 14:40

Panel Discussion

Jin Jung (The Catholic University of Korea, Korea), Ho Geol Woo (Kyung Hee University, Korea)

Seongheon Kim (Kangwon National University, Korea), Jong-Moo Park (Eulji University, Korea)
14:40 - 15:00

Coffee Break
15:00 - 15:40 Plenary Lecture 2
15:00 - 15:40
Plenary Lecture 2
  • Home blood pressure monitoring (HBPM) is a reliable, convenient, and less costly alternative to ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of hypertension. Recognition and use of HBPM have dramatically increased over the last 20 years and current guidelines make strong recommendations for the use of both HBPM and ABPM in patients with hypertension. In this plenary lecture, Prof. Takayoshi Ohkubo from Teikyo University School of Medicine, Japan will give us a wonderful lecture on the current knowledge and his experience in Japan on significance of home blood pressure measurement.

Chairpersons

Kyung-Yul Lee (Yonsei University, Korea)
15:00 - 15:40

Significance of Home Blood Pressure Measurement : Perspectives from Experience In Japan

Takayoshi Ohkubo (Teikyo University School of Medicine, Japan)
15:40 - 17:20 Symposium 5
KSCP-ASPC Joint Session: Comprehensive Cardiovascular Health: Risks and Prevention Strategies
15:40 - 17:20
Symposium 5
KSCP-ASPC Joint Session: Comprehensive Cardiovascular Health: Risks and Prevention Strategies

Organizer : Hyeon Chang Kim (Yonsei University, Republic of Korea)

  • Comprehensive Approach in Cardiovascular Prevention, a special event from the collaboration between the American Society for Preventive Cardiology (ASPC) and the Korean Society of Cardiovascular Disease Prevention (KSCP).
  • This session will highlight innovative strategies for preventing cardiovascular disease. Dr. Heather M. Johnson will discuss the link between adverse pregnancy outcomes and cardiovascular disease.
  • Dr. Jong Chan Yoon will explore prevention strategies for cardiovascular disease among cancer survivors. Dr. Charles German will highlight the role of physical activity measurement in risk assessment, and Dr. Hyeon Chang Kim will address the impact of socioeconomic factors on cardiovascular health.
  • This joint session offers a unique opportunity to learn from leading experts and advance your knowledge of cardiovascular prevention. Don’t miss out on these valuable insights and discussions.

Chairpersons

Heather M. Johnson (Florida Atlantic University, USA)
Dae Jung Kim (Ajou University, Korea)

15:40 - 16:00

Evaluating Blood Pressure Patterns and Developing Interventions for Hypertensive Disorders of Pregnancy

Heather M. Johnson (Florida Atlantic University, USA)
16:00 - 16:20

Prevention of Cardiovascular Disease among Cancer Survivors

Mi-Hyang Jung (The Catholic University of Korea, Korea)
16:20 - 16:40

Measurement of Physical Activity for Cardiovascular Disease Risk Assessment

Charles German (Georgetown University, USA)
16:40 - 17:00

Measurement of Socioeconomic Factors for Cardiovascular Disease Risk Assessment

Hyeon Chang Kim (Yonsei University, Korea)
17:00 - 17:20

Panel Discussion

Hokyou Lee (Yonsei University, Korea), Dae Young Cheon (Hallym University, Korea)

Song Vogue Ahn (Ewha Womans University, Korea)
17:20 - 18:00 Satellite Symposium 1 [ Yuhan & Hanmi Pharmaceutical ]
17:20 - 18:00
Satellite Symposium 1 [ Yuhan & Hanmi Pharmaceutical ]

Chairpersons

Jong-Young Lee (Sungkyunkwan University, Korea)
Won-Young Lee (Sungkyunkwan University, Korea)
17:20 - 17:40

Various Angles of Full Spectrum of Empagliflozin in Chronic Heart Failure

Hyo-In Choi (Sungkyunkwan University, Korea)
17:40 - 18:00

It’s Time to Break Therapeutic Inertia in Dyslipidemia Treatment

Eu Jeong Ku (Seoul National University, Korea)
09:00 - 10:40 Symposium 2
Updates on Novel Drugs in the Field of Diabetes and Obesity
09:00 - 10:40
Symposium 2
Updates on Novel Drugs in the Field of Diabetes and Obesity

Chairpersons

Junghyun Noh (Inje University, Korea)
Seonghoon Choi (Hallym University, Korea)
09:00 - 09:20

Effects of SGLT1/2 Dual Inhibitors on Cardiovascular Risk

Eun-Jung Rhee (Sungkyunkwan University, Korea)
09:20 - 09:40

Tirzepatide Treatment and Cardiovascular Risk Factors

Clare Lee (Eli Lilly and Company, USA)
09:40 - 10:00

Transforming Obesity Care: Next-Gen Treatments for Weight Loss

Jang Won Son (The Catholic University of Korea, Korea)
10:00 - 10:20

Weekly Insulin: Pharmacokinetics/Dosing Strategy and Clinical Outcome

Se Eun Park (Sungkyunkwan University, Korea)
10:20 - 10:40

Panel Discussion

Eugene Han (Keimyung University, Korea), Shinje Moon (Hanyang University, Korea)

Boyeon Kim (Soonchunhyang University, Korea)
10:40 - 11:00

Coffee Break
11:00 - 11:10 Opening Address
11:00 - 11:10
Opening Address
11:10 - 11:50 Plenary Lecture 1
11:10 - 11:50
Plenary Lecture 1
  • Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein cholesterol (LDL cholesterol), and most often caused by a defect in 3 different genes (LDL-receptor gene, PCSK 9 gene and Apo B gene). As the FH affects the way the body processes cholesterol, people with FH have a higher risk of heart disease and a greater risk of early heart attack. In this plenary lecture, the world renowned expert in FH research, Professor Brian Tomlinson from Macau University of Science and Technology, Macau, China will provide us with beautiful insights and future perspectives in the field of diagnosis and treatment of FH.

Chairpersons

Won-Young Lee (Sungkyunkwan University, Korea)
11:10 - 11:50

Familial Hypercholesterolaemia, Diagnosis and Management

Brian Tomlinson (Macau University of Science and Technology, Macao SAR)
11:50 - 12:30 Luncheon Symposium 2 [ LG Chem & Dong-A ST ]
11:50 - 12:30
Luncheon Symposium 2 [ LG Chem & Dong-A ST ]

Chairperson

Sung Rae Kim (The Catholic University of Korea, Korea)
11:50 - 12:10

Gemigliptin, Fundamental and Essential Medication in T2DM Management

Jun Hwa Hong (Eulji University, Korea)
12:10 - 12:30

Importance of 24h BP Control for Reducing CVD Risk; The Role of Edarbi

Jong-Young Lee (Sungkyunkwan University, Korea)
12:30 - 13:00

Break
13:00 - 14:40 Symposium 4
Chronic Diseases/Cardiovascular Diseases in the Elderly
13:00 - 14:40
Symposium 4

Chairpersons

Eun-Jung Rhee (Sungkyunkwan University, Korea)
Seonghoon Choi (Hallym University, Korea)
13:00 - 13:20

Disease Burden and Health Care Costs in Korean Elderly

Seok-Jun Yoon (Korea University, Korea)
13:20 - 13:40

Cardiovascular Diseases in the Elderly

Kwang-il Kim (Seoul National University, Korea)
13:40 - 14:00

Current Insights and Individualized Approaches in Elderly Diabetes

Jae-Seung Yun (The Catholic University of Korea, Korea)
14:00 - 14:20

Stroke in the Elderly

Chi Kyung Kim (Korea University, Korea)
14:20 - 14:40

Panel Discussion

Eun Joo Lee (University of Ulsan, Korea), Joo Hyun Lim (Korea Disease Control and Prevention Agency(KDCA))

Seung Jin Han (Ajou University, Korea), Jung Yeon Choi (Seoul National University, Korea)
14:40 - 15:00

Coffee Break
15:00 - 15:40 Plenary Lecture 2
15:00 - 15:40
Plenary Lecture 2
  • Home blood pressure monitoring (HBPM) is a reliable, convenient, and less costly alternative to ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of hypertension. Recognition and use of HBPM have dramatically increased over the last 20 years and current guidelines make strong recommendations for the use of both HBPM and ABPM in patients with hypertension. In this plenary lecture, Prof. Takayoshi Ohkubo from Teikyo University School of Medicine, Japan will give us a wonderful lecture on the current knowledge and his experience in Japan on significance of home blood pressure measurement.

Chairpersons

Kyung-Yul Lee (Yonsei University, Korea)
15:00 - 15:40

Significance of Home Blood Pressure Measurement : Perspectives from Experience In Japan

Takayoshi Ohkubo (Teikyo University School of Medicine, Japan)
15:40 - 17:20 Symposium 6
Integrated Approach to CKD Management Including Hypertension, Dyslipidemia, and Diabetes
15:40 - 17:20
Symposium 6
Integrated Approach to CKD Management Including Hypertension, Dyslipidemia, and Diabetes

Organizer : Eun Hui Bae (Chonnam National University, Republic of Korea)

  • Integrated Approach to CKD Management Including Hypertension, Dyslipidemia, and Diabetes, must attend the session at our upcoming conference.
  • This session will cover innovative therapeutic strategies for managing CKD with hypertension, presenting the latest updates in hypertension guidelines.
  • It will also delve into the newest guidelines for dyslipidemia management in CKD, focusing on practical applications to optimize lipid control and reduce cardiovascular risk.
  • Additionally, the symposium will explore prevention and early intervention strategies in diabetic kidney disease, highlighting the latest guidelines which aimed at delaying disease progression.
  • Furthermore, the session will discuss how artificial intelligence is being leveraged to advance research in hypertension, showcasing AI-driven innovations that have the potential to revolutionize hypertension management.
  • Don’t miss this opportunity to enhance your knowledge and clinical practice in managing CKD and its associated conditions.
  • We look forward to your participation!

Chairpersons

Bum Soon Choi (The Catholic University of Korea, Korea)
Jaetaek Kim (Chung-Ang University, Korea)
15:40 - 16:00

Innovative Therapeutic Strategies in CKD with Hypertension: Update in HTN Guideline in CKD

Jeonghwan Lee (Seoul National University, Korea)
16:00 - 16:20

Dyslipidemia and Cardiovascular Health in CKD Patients

Tae Hyun Ban (The Catholic University of Korea, Korea)
16:20 - 16:40

Prevention and Early Intervention in Diabetic Kidney Disease: Update Guideline in DKD

Su Hyun Song (Chonnam National University, Korea)
16:40 - 17:00

Leveraging AI for Hypertension Research Advances

Jae Boum Youm (Inje University, Korea)
17:00 - 17:20

Panel Discussion

Eun Hui Bae (Chonnam National University, Korea), Dae Eun Choi (Chungnam National University, Korea)

Su Hyun Kim (Chung-Ang University, Korea), Wonmin Hwang (Konyang University, Korea)
17:20 - 18:00 Satellite Symposium 2 [HK inno.N & JW Pharmaceutical ]
17:20 - 18:00
Satellite Symposium 2 [HK inno.N & JW Pharmaceutical ]

Chairpersons

Eun-Jung Rhee (Sungkyunkwan University, Korea)
Seung-Hyun Ko (The Catholic University of Korea, Korea)
17:20 - 17:40

The Optimal Combination for Treating Diabetes with Original Dapagliflozin

Kyeong Jin Kim (Korea University, Korea)
17:40 - 18:00

Cutting Edge Care of Pitavastatin with Ezetimibe Combination Therapy

Dughyun Choi (Soonchunhyang University, Korea)